Stock Analiz

MiniMed Group, Inc. (MMED) stock forecast and price target

Price $17.99 · data as of November 13, 2026

12-month price target

Average target$25.33
Upside / downside+40.8%
Analysts15
ConsensusBuy
Low $15.00Average $25.33High $30.00

Gold marker: average target · white marker: today’s price ($17.99)

Analyst ratings

Strong buy 0Buy 12Hold 3Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends April 30, 2027
$0.70+225.5%$3.4B
Next fiscal year
ends April 30, 2028
$0.71+0.8%$3.7B
Quarter after
ends January 31, 2027
$0.20+168.5%$861M

Consensus of the analysts covering MiniMed Group, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 40.8% upside over 12 months. Our discounted cash flow model with moderate assumptions puts MiniMed Group’s intrinsic value about 67% below today’s market value, and it scores 1.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the MiniMed Group stock price target?

The average 12-month target from 15 analysts is $25.33, 40.8% above the current price of $17.99 Targets range from $15.00 to $30.00.

Is MiniMed Group a buy according to analysts?

The consensus rating is “Buy” (12 buy, 3 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is MiniMed Group expected to earn?

Analysts expect EPS of $0.70 for the fiscal year ending April 30, 2027 and $0.71 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.